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Abstract
Introduction Bile acid diarrhoea (BAD) can occur due to disruption to the enterohepatic circulation, e.g. following
cholecystectomy. Post-cholecystectomy diarrhoea has been reported in 2.1–57.2% of patients; however, this is not
necessarily due to BAD. The aim of this study was to determine the rates of bile acid diarrhoea diagnosis after
cholecystectomy and to consider investigation practices.
Methods A retrospective analysis of electronic databases from five large centres detailing patients who underwent
laparoscopic cholecystectomy between 2013 and 2017 was cross-referenced with a list of patients who underwent
75SeHCAT testing. A 7-day retention time of\15% was deemed to be positive. Patient demographics and time from
surgery to investigation were collected and compared for significance (p\ 0.05).
Results A total of 9439 patients underwent a laparoscopic cholecystectomy between 1 January 2013 and 31
December 2017 in the five centres. In total, 202 patients (2.1%) underwent investigation for diarrhoea via 75SeHCAT,
of which 64 patients (31.6%) had a 75SeHCAT test result of[15%, while 62.8% of those investigated were diagnosed
with bile acid diarrhoea (BAD). In total, 133 (65.8%) patients also underwent endoscopy and 74 (36.6%) patients had
a CT scan. Median time from surgery to 75SeHCAT test was 672 days (SD ± 482 days).
Discussion/Conclusion Only a small proportion of patients, post-cholecystectomy, were investigated for diarrhoea
with significant time delay to diagnosis. The true prevalence of BAD after cholecystectomy may be much higher, and
clinicians need to have an increased awareness of this condition due to its amenability to treatment. 75SeHCAT is a
useful tool for diagnosis of bile acid diarrhoea.
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Cholecystectomy is a common surgical procedure per-
formed for diseases of the gallbladder, commonly offered
for the treatment of symptomatic gallstones [1]. However,
post-operatively some patients may develop symptoms
which can cause discomfort and disruption to their quality
of life, one of which is diarrhoea. The frequency of diar-
rhoea in the post-operative period is highly variable with
previous studies identifying prevalence of up to 57.2%
[2–6]. The high variability within the literature is the result
of most studies not being specifically powered to investi-
gate post-cholecystectomy diarrhoea. One of the causes of
post-cholecystectomy diarrhoea is bile acid diarrhoea
(BAD) [7].
The British Society of Gastroenterology (BSG) guide-
lines for investigation of chronic diarrhoea suggest endo-
scopic examination and a 75SeHCAT scan as first-line
investigations[8]. 75SeHCAT testing is useful to determine
bile acid diarrhoea where patients who have a less than
15% retention of gamma-emitting Selenium-75-homo-
cholic acid taurine are diagnosed with bile acid diarrhoea.
This is divided into three groups, with 11–15% retention
classified as mild, while 6–10% retention is moderate and
less than 5% is severe. The cut-off value of 15% demon-
strated a 100% sensitivity and 91% specificity [9]. While
there are other ways of diagnosing BAD such as using
serum C4 and faecal bile acid levels, the 75SeHCAT scan is
more commonly used in the UK [10]. It is a condition
which is amenable to treatment with bile acid sequestrants;
however, it is often overlooked [10].
In this study we aimed to accurately determine the
incidence of post-cholecystectomy diarrhoea across a
number of hospital sites, how many patients are investi-
gated, and how much of this is bile acid diarrhoea.
Methods
This project was a multicentre retrospective study. Local
approval was sought from the Research and Development
unit of each centre separately for retrospective review of
data.
An electronic retrospective database of patients under-
going laparoscopic cholecystectomy between January 2013
and December 2017 was cross-referenced with all the
patients who underwent 75SeHCAT testing during the same
time period at these centres. A 7-day75SeHCAT retention
of less than 15% was deemed to be positive. Patient
demographics were collected and compared for signifi-
cance (p\ 0.05) Mann–Whitney U test. Time from sur-
gery to investigation was also noted, and any differences
between men and women were compared using a Mann–
Whitney U test. To further investigate this, a log of the
time from cholecystectomy to investigation was taken and
a Student T test was used to determine whether there were
still differences in investigation times. To further quantify
this difference, a regression model of time to investigation
adjusted for sex was also performed. Statistical advice was
sought in the data analysis.
Results
A total of 9439 patients underwent a laparoscopic chole-
cystectomy between 1 January 2013 and 31 December
2017 in five UK centres: Oxford University Hospitals,
North Bristol NHS Trust; Royal United Hospitals Bath
NHS Trust, Queen Elizabeth University Hospital Glasgow
and University Hospitals Coventry, and Warwickshire
NHS Trust. Of these, 202 patients (2.1%) were investigated
for BAD via 75SeHCAT.
Demographic data
The sampled population consisted of 160 female patients
(80%) and 42 male patients (20%). The age range of
patients was from 20 to 90 with the highest number of
patients diagnosed with BAD between the ages of 46 and
50. All patients younger than 35 were females, and the
proportion of male patients increased after the age of 51.
This is shown in Table 1, and the proportion of diagnosis is
shown in Fig. 1.
Of patients included in the study, 10 patients had known
inflammatory bowel disease (IBD) prior to laparoscopic
cholecystectomy, this being Crohn’s disease (six patients),
ulcerative colitis (one patient), or indeterminate colitis
(three patients). Five patients had had terminal ileal
resection, only one of which had Crohn’s disease.
In total, 127 patients were diagnosed with bile acid
diarrhoea (62.8% of those investigated), and four patients
were newly diagnosed with IBD. Nine patients were
diagnosed with IBS, and two were diagnosed as chronic
pancreatic insufficiency and four as chronic cholecystitis.
One patient was diagnosed with an insulinoma of the
pancreas, another with Sphincter of Oddi dysfunction, one
with dumping syndrome, and another with functional
bowel disorder. However, 38 patients (18.8%) had a
diagnosis of ‘unknown’ at the end. This is also seen in
Table 1.
Indications for 75SeHCAT testing
Indications for 75SeHCAT referral were mainly due to
diarrhoea, chronic diarrhoea, loose stool, or watery stool
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(137 patients). In total, 21 patients were simply referred as
‘‘query of bile acid diarrhoea’’ or ‘‘bile acid malabsorp-
tion’’. Seven patients were listed as having a change in
bowel habit, and a further 17 patients reported abdominal
pain, often accompanied by diarrhoea. Other reasons for
referral included steatorrheoa and bloating.
Other investigations
In total, 133 (65.8%) patients also underwent endoscopic
examination (colonoscopy or flexible sigmoidoscopy) of
which 86 were normal, 29 showed diverticular disease, 16
showed polyps (tubular adenomas), and two showed mild
inflammation. Of those with a normal endoscopy, 43 were
eventually diagnosed as having BAD.
In total, 74 (36.6%) patients had a CT scan of the
abdomen and pelvis. Of these, 45 were normal, 11 showed
diverticular disease, 2 demonstrated inflammatory bowel
disease, and 15 showed non-bowel-related pathology.
75SeHCAT results and correlation with symptoms
The distribution of patients and their 75SeHCAT results is
shown in Table 2. All patients had diarrhoea duration of
[4 weeks. In total, 104 patients had one to five episodes
per day, 34 had six to ten episodes a day, 10 patients had
eleven to fifteen episodes per day, and 3 patients had more
than fifteen episodes per day. For the remainder, bowel
frequency was not recorded by the assessing clinician.
There was no significant correlation between the
75SeHCAT result and the number of episodes of diarrhoea
per day (p = 0.382, using Chi-squared test). This is also
seen in Table 2.
Table 1 Demographics












20–25 9 (0:9) 6 (2.9%) 1 (0.5%) 7 (3.5%) 0 1 (0.5%) 0
26–30 13 (0:12) 8 (3.9%) 4 (1.9%) 11 (5.4%) 0 0 2 (0.9%)
31–35 11 (0:11) 5 (2.5%) 1 (0.5%) 7 (3.5%) 1 (0.5%) 0 2 (0.9%)
36–40 17 (2:13) 9 (4.5%) 5 (2.5%) 10 (4.9%) 0 1 (0.5%) 2 (0.9%)
41–45 27 (4:23) 17 (8.4%) 8 (3.9%) 14 (6.9%) 0 1 (0.5%) 8 (3.9%)
46–50 25 (3:22) 15 (7.4%) 6 (2.9%) 18 (8.9%) 1 (0.5%) 1 (0.5%) 1 (0.5%)
51–55 26 (7:19) 16 (7.9%) 6 (2.9%) 15 (7.4%) 0 3 (1.5%) 4 (1.9%)
56–60 19 (4:15) 13 (6.4%) 6 (2.9%) 12 (5.9%) 0 1 (0.5%) 4 (1.9%)
61–65 21 (7:14) 14 (6.9%) 12 (5.9%) 9 (4.5%) 1 (0.5%) 0 8 (3.9%)
66–70 11 (4:7) 11 (5.4%) 6 (2.9%) 8 (3.9%) 0 1 (0.5%) 1 (0.5%)
71–75 15 (5:10) 11 (5.4%) 7 (3.5%) 10 (4.9%) 1 (0.5%) 0 3 (1.5%)
76–80 7 (4:3) 2 (0.9%) 5 (2.5%) 4 (1.9%) 0 0 1 (0.5%)
81–85 2 (0:2) 2 (0.9%) 2 (0.9%) 1(0.5%) 0 0 1 (0.5%)
86–90 2 (2:0) 1 (0.5%) 0 1 (0.5%) 0 0 1 (0.5%)
Fig. 1 Diagnosis (BAD bile acid diarrhoea; IBD inflammatory
bowel disease; IBS irritable bowel syndrome)
Table 2 75SeHCAT results and correlation with bowel habits
75SeHCAT results \5% 6–10% 11–15% [15%
Total 72 40 26 64
Male 17 11 4 10
Female 55 29 22 54
1–5 episodes/day 28 19 16 41
6–10 episodes/day 20 6 2 6
11–15 episodes/day 5 3 1 1




There was no significant difference between men and
women in time from laparoscopic cholecystectomy to
referral for 75 SeHCAT scan or endoscopy. There was a
significant difference between referral time for men and
women for CT scan (p = 0.022); however, this does not
hold up on taking a log and performing a Students’ t test, or
on performing a regression analysis adjusting for sex. This
is shown in Table 3 and Figs. 2, 3, and 4
Discussion
One reason for the development of post-cholecystectomy
diarrhoea is from disruption to the enterohepatic circula-
tion, causing hepatic overproduction of bile acids. This is
known as bile acid diarrhoea (BAD) of which there are
three types: type one occurs secondary to ileal inflamma-
tion, thus interfering with bile acid absorption; type two is
primary or idiopathic; and type three occurs secondary to
other conditions where the ileum appears normal. In the
latter, one of these conditions is following cholecystectomy
[11, 12].
The mechanism of action to balance bile acid secretion
is a negative feedback loop. Bile acid reabsorption in the
ileum leads to activation of ileal FXR (farnesoid 9
receptor), thus inducing transcription of FGF19 (fibroblast
growth factor 19) which then activates hepatic FXR. This
inhibits CYP7A1 (cholesterol 7-ahydroxylase), which is
the rate-limiting enzyme in bile acid synthesis, thus
decreasing bile acid formation. When this is disrupted, as
in BAD, there is overproduction of FGF19 leading to
higher concentrations of bile acids which, in turn, leads to
diarrhoea [12, 13].
In this study involving collaboration from five tertiary
centres, only a small number of patients (2.1%) were
investigated for diarrhoea following laparoscopic chole-
cystectomy. This may imply either that the rest of the
patients did not require any investigation as they did not
develop diarrhoea, or that their symptoms were short term
and settled spontaneously without warranting medical
investigation. The published literature reveals a large











Regression analysis p value (hazard ratio
with 95%CI)
75SeHCAT 672 (482) 726 (461) 539 (548) 0.139 0.212 0.55 (0.901; 0.63.–1.277)
Endoscopy 696 (545) 723 (517) 545 (623) 0.290 0.66 0.739 (1.078; 0.691–1.682)
CT 778 (595) 938 (531) 388 (709) 0.022 0.41 0.323 (1.39; 0.723–2.674)
Fig. 2 Regression analysis for time to 75 SEHCAT, adjusted for
sex
Fig. 3 Regression analysis for time to endoscopy, adjusted for sex
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variation in the quoted incidence of post-cholecystectomy
diarrhoea. This ranges from 2.1 to 57.2% [2–6, 14]. Our
own review of the literature showed a post-cholecystec-
tomy diarrhoea rate of 13% (Farrugia et al., Post-Chole-
cystectomy diarrhoea rate and predictive factors—a
systematic review of the literature). Despite this, the true
rate of post-cholecystectomy diarrhoea due to altered bile
acid physiology has not been determined. C4 (7a-hydroxy-
4-cholesten-3-one) levels, which directly correlate with
bile acid synthesis, have been shown to increase following
cholecystectomy, while FGF19 levels decrease [5, 15].
Despite this, the increase in C4 levels has not been shown
to be related to increased frequency of bowel movements
or type of stool [5].
Thus, the number of patients being investigated does not
necessarily correlate with the presumed rate of post-c-
holecystectomy diarrhoea that is reported in the literature.
This may be due to a lack of awareness that diarrhoea may
develop after cholecystectomy due to faults in the pre-op-
erative consent process. Indeed, up to 70.3% of patients are
not being consented for the possibility of developing
diarrhoea after laparoscopic cholecystectomy [16].
There is a clear delay in initiating investigations, with a
median of 672 days between surgery and 75SeHCAT test-
ing found in this study, implying that there is poor
awareness within the medical community of the possibility
of developing BAD after cholecystectomy. There was a
difference in time to investigation between women and
men, with median time to testing for female patients being
726 days while median time to testing for male patients,
539 days. While not statistically significant (p = 0.139),
there is a median difference of 187 days. This may imply
that complaints are not well regarded and in indeed one
study suggests that there is a perceived reduction in con-
stipation in women after cholecystectomy, but no real
diarrhoea [17]. However, we can see from our results that it
is not simply perception as patients have had positive
75SeHCAT tests after developing diarrhoea post-
cholecystectomy.
Furthermore, we have noted that not all patients
underwent endoscopic investigation in addition to
75SeHCAT testing, as is recommended by the British
Society of Gastroenterology guidelines [8]. This could also
imply that inflammatory bowel disease (IBD) was not
excluded in all patients. As IBD (ileal Crohn’s) can be a
cause of BAD, this is a confounding factor in our study.
Another confounding factor is that some patients were
known to have Crohn’s disease prior to laparoscopic
cholecystectomy and others had had a previous right
hemicolectomy for other conditions. As both of these
factors affect the terminal ileum and may lead to bile acid
malabsorption, it is unclear, for these patients, whether the
BAD that developed was a consequence of malabsorption
from the terminal ileum, or from bile acid overproduction
following cholecystectomy, or perhaps a mixture of both.
With endoscopic investigations there was an added delay
of 178 days between women and men (median of 723 days
for women and 545 days for men). Whilst failing to reach
statistical significance (p = 0.29), it does represent an extra
period of time with a reduced quality of life [18].
Despite CT scan being more useful in the investigation
of structural rather than functional disorders, a large
number of patients still had a CT scan as part of their initial
investigation. In this there was a significant difference
between referral time for women and men (p = 0.022),
938 days for women and 388 days for men. For all
investigations, the median time to investigation of female
patients was longer. This is a pattern that has been previ-
ously reported in other aspects of healthcare, resulting in
higher morbidity and mortality for female patients [19, 20].
It is also interesting as CT scan is not recommended by the
BSG guidelines for the investigation of chronic diarrhoea.
However, there may have been other aspect if the clinical
history led to a referral for CT scan.
Despite men being investigated (75SeHCAT, endoscopy
and CT scan) more rapidly from initial presentation com-
pared to women, we can still see that there is a significant
delay in initiating investigations after laparoscopic chole-
cystectomy with a median time to investigation longer than
18 months for each investigation. Symptoms tend to
develop within the first 3 months after cholecystectomy,
and it is therefore apparent that these patients are not being
investigated in a timely manner [21] and to the detriment of
their quality of life [18]. However, there may be other
Fig. 4 Regression analysis for time to CT, adjusted for sex
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issues at play such as social factors preventing some
patients from seeking help or attending for tests, delays
resulting from local processes such as referral practices and
waiting list times for tests such as 75SeHCAT (which is not
found in all centres) and endoscopy waiting times. As such,
it is difficult to say what effect this has on time from
cholecystectomy to testing. As this is a multicentre study
there may also be differences in practice between regions
to take into account.
This study has confirmed that the degree of BAD, as
seen on the 75SeHCAT result, does not necessarily corre-
late with patient symptoms (p = 0.382), which is in keep-
ing with previous work on the subject [22]. However, all
patients were investigated after having diarrhoea for
4 weeks and the majority had a up to 10 episodes per day,
which is congruent with the BSG guidelines for the
investigation of chronic diarrhoea [8]. It is also interesting
to note that whilst 62.8% of the cohort was diagnosed with
BAD and 18.4% had another diagnosis, in 18.8% of
patients a definitive diagnosis was not secured. This high-
lights that further work is required in this area to benefit
this large group of patients with clinical symptoms.
We found that patients younger than 35 years of age
were all females and there are generally fewer males in
each age group under the age of 50. This seems to imply
that younger women are at higher risk of developing PCD
in our dataset. This correlates with some studies [23] but
not with others that suggest younger males to be more at
risk [4, 24, 25].
This study is based upon real-time linked clinical data,
thus showing the true perspective of patients who were
investigated post-laparoscopic cholecystectomy for diar-
rhoea. Patients who were empirically started on bile acid
sequestrants rather than being investigated via 75SeHCAT
would not have been captured in the present study. Another
possible limitation is that not all patients who develop
diarrhoea are investigated via 75SeHCAT; thus, the true
numerator remains unknown. BAD is not a well-known
condition, and therefore, the only patients who were
referred for 75SeHCAT testing were those seen by GPs,
physicians, and surgeons who are aware of the condition.
We also have no data regarding response to treatment in
these patients identified here who were diagnosed with
BAD. We have identified a large discrepancy between the
number of male and female patients within our dataset, as
such there may be an element of selection bias. However,
the advantage of this study is that it is a multicentre study
using 75SeCHAT as the investigation of choice with
defined cut-off values for diagnosis of BAD. It also
benchmarks the current clinical scenario when it comes to
the investigation of chronic diarrhoea after cholecystec-
tomy. While this is the largest study of its kind to date,
further studies involving direct comparison between those
patients investigated, and those who are not, for diarrhoea
following cholecystectomy would present a more com-
prehensive picture of this difficult condition and would not
only improve our understanding but allow for improved
patient care.
Conclusion
A small proportion of post-cholecystectomy patients were
investigated for BAD (2.1%), and in those that were
investigated 62.8% were positive for BAD as indicated by
75SeHCAT testing (75SeHCAT results\15%). There was a
significant time delay to diagnosis following the onset of
symptoms. This may in part be because cholecystectomy is
mostly undertaken as a day case procedure and routine
follow-up is rarely required. The true prevalence of BAD
post-cholecystectomy may be much higher, and clinicians
in both primary and secondary care need to have an
increased awareness of this condition due to its amenability
to treatment. Other options including serum C4 and faecal
measurements of bile acid remain alternatives where75-
SeHCAT is unavailable.
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